Go Pro

CT Private Equity Trust (CTPE) Competitors

CT Private Equity Trust logo
GBX 470 0.00 (0.00%)
As of 12:49 PM Eastern

CTPE vs. ASL, WWH, JMG, TMPL, and IHP

Should you buy CT Private Equity Trust stock or one of its competitors? CT Private Equity Trust's main competitors and comparable companies include Aberforth Smaller Companies Trust (ASL), Worldwide Healthcare (WWH), JPMorgan Emerging Markets (JMG), Temple Bar (TMPL), and IntegraFin (IHP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does CT Private Equity Trust compare to Aberforth Smaller Companies Trust?

Aberforth Smaller Companies Trust (LON:ASL) and CT Private Equity Trust (LON:CTPE) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability.

Aberforth Smaller Companies Trust has a beta of 1.433, meaning that its share price is 43% more volatile than the broader market. Comparatively, CT Private Equity Trust has a beta of 0.899, meaning that its share price is 10% less volatile than the broader market.

In the previous week, Aberforth Smaller Companies Trust's average media sentiment score of 0.00 equaled CT Private Equity Trust'saverage media sentiment score.

Company Overall Sentiment
Aberforth Smaller Companies Trust Neutral
CT Private Equity Trust Neutral

Aberforth Smaller Companies Trust has higher revenue and earnings than CT Private Equity Trust. CT Private Equity Trust is trading at a lower price-to-earnings ratio than Aberforth Smaller Companies Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aberforth Smaller Companies Trust£94.68M13.90£255.01M£115.7814.87
CT Private Equity Trust£36.40M9.21£5.40M£49.049.58

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aberforth Smaller Companies Trust
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
CT Private Equity Trust
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

CT Private Equity Trust has a net margin of 73.44% compared to Aberforth Smaller Companies Trust's net margin of 63.47%. CT Private Equity Trust's return on equity of 7.01% beat Aberforth Smaller Companies Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Aberforth Smaller Companies Trust63.47% 6.52% 11.67%
CT Private Equity Trust 73.44%7.01%1.91%

Aberforth Smaller Companies Trust pays an annual dividend of GBX 46.80 per share and has a dividend yield of 2.7%. CT Private Equity Trust pays an annual dividend of GBX 28.22 per share and has a dividend yield of 6.0%. Aberforth Smaller Companies Trust pays out 40.4% of its earnings in the form of a dividend. CT Private Equity Trust pays out 57.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

13.1% of Aberforth Smaller Companies Trust shares are held by institutional investors. Comparatively, 16.8% of CT Private Equity Trust shares are held by institutional investors. 0.4% of Aberforth Smaller Companies Trust shares are held by company insiders. Comparatively, 0.3% of CT Private Equity Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Aberforth Smaller Companies Trust beats CT Private Equity Trust on 9 of the 15 factors compared between the two stocks.

How does CT Private Equity Trust compare to Worldwide Healthcare?

Worldwide Healthcare (LON:WWH) and CT Private Equity Trust (LON:CTPE) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

Worldwide Healthcare pays an annual dividend of GBX 2.40 per share and has a dividend yield of 0.6%. CT Private Equity Trust pays an annual dividend of GBX 28.22 per share and has a dividend yield of 6.0%. Worldwide Healthcare pays out 9.0% of its earnings in the form of a dividend. CT Private Equity Trust pays out 57.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Worldwide Healthcare has a net margin of 85.46% compared to CT Private Equity Trust's net margin of 73.44%. Worldwide Healthcare's return on equity of 8.01% beat CT Private Equity Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Worldwide Healthcare85.46% 8.01% -2.02%
CT Private Equity Trust 73.44%7.01%1.91%

7.7% of Worldwide Healthcare shares are held by institutional investors. Comparatively, 16.8% of CT Private Equity Trust shares are held by institutional investors. 0.2% of Worldwide Healthcare shares are held by insiders. Comparatively, 0.3% of CT Private Equity Trust shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Worldwide Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
CT Private Equity Trust
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Worldwide Healthcare has a beta of 0.262, suggesting that its stock price is 74% less volatile than the broader market. Comparatively, CT Private Equity Trust has a beta of 0.899, suggesting that its stock price is 10% less volatile than the broader market.

Worldwide Healthcare has higher revenue and earnings than CT Private Equity Trust. CT Private Equity Trust is trading at a lower price-to-earnings ratio than Worldwide Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Worldwide Healthcare£118.16M11.11£227.88M£26.7014.04
CT Private Equity Trust£36.40M9.21£5.40M£49.049.58

In the previous week, Worldwide Healthcare had 2 more articles in the media than CT Private Equity Trust. MarketBeat recorded 2 mentions for Worldwide Healthcare and 0 mentions for CT Private Equity Trust. Worldwide Healthcare's average media sentiment score of 1.85 beat CT Private Equity Trust's score of 0.00 indicating that Worldwide Healthcare is being referred to more favorably in the media.

Company Overall Sentiment
Worldwide Healthcare Very Positive
CT Private Equity Trust Neutral

Summary

Worldwide Healthcare beats CT Private Equity Trust on 9 of the 17 factors compared between the two stocks.

How does CT Private Equity Trust compare to JPMorgan Emerging Markets?

CT Private Equity Trust (LON:CTPE) and JPMorgan Emerging Markets (LON:JMG) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability.

16.8% of CT Private Equity Trust shares are owned by institutional investors. Comparatively, 14.8% of JPMorgan Emerging Markets shares are owned by institutional investors. 0.3% of CT Private Equity Trust shares are owned by company insiders. Comparatively, 0.0% of JPMorgan Emerging Markets shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

CT Private Equity Trust has a beta of 0.899, meaning that its stock price is 10% less volatile than the broader market. Comparatively, JPMorgan Emerging Markets has a beta of 0.906, meaning that its stock price is 9% less volatile than the broader market.

In the previous week, JPMorgan Emerging Markets had 1 more articles in the media than CT Private Equity Trust. MarketBeat recorded 1 mentions for JPMorgan Emerging Markets and 0 mentions for CT Private Equity Trust. JPMorgan Emerging Markets' average media sentiment score of 0.67 beat CT Private Equity Trust's score of 0.00 indicating that JPMorgan Emerging Markets is being referred to more favorably in the news media.

Company Overall Sentiment
CT Private Equity Trust Neutral
JPMorgan Emerging Markets Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CT Private Equity Trust
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
JPMorgan Emerging Markets
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

CT Private Equity Trust pays an annual dividend of GBX 28.22 per share and has a dividend yield of 6.0%. JPMorgan Emerging Markets pays an annual dividend of GBX 1.95 per share and has a dividend yield of 1.4%. CT Private Equity Trust pays out 57.5% of its earnings in the form of a dividend. JPMorgan Emerging Markets pays out 42.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

JPMorgan Emerging Markets has a net margin of 95.26% compared to CT Private Equity Trust's net margin of 73.44%. JPMorgan Emerging Markets' return on equity of 19.61% beat CT Private Equity Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
CT Private Equity Trust73.44% 7.01% 1.91%
JPMorgan Emerging Markets 95.26%19.61%1.55%

JPMorgan Emerging Markets has higher revenue and earnings than CT Private Equity Trust. CT Private Equity Trust is trading at a lower price-to-earnings ratio than JPMorgan Emerging Markets, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CT Private Equity Trust£36.40M9.21£5.40M£49.049.58
JPMorgan Emerging Markets£56.31M23.64£80.10M£4.6329.33

Summary

JPMorgan Emerging Markets beats CT Private Equity Trust on 10 of the 17 factors compared between the two stocks.

How does CT Private Equity Trust compare to Temple Bar?

Temple Bar (LON:TMPL) and CT Private Equity Trust (LON:CTPE) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

Temple Bar has higher revenue and earnings than CT Private Equity Trust. Temple Bar is trading at a lower price-to-earnings ratio than CT Private Equity Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Temple Bar£222.42M5.73£154.90M£75.205.51
CT Private Equity Trust£36.40M9.21£5.40M£49.049.58

Temple Bar pays an annual dividend of GBX 15.15 per share and has a dividend yield of 3.7%. CT Private Equity Trust pays an annual dividend of GBX 28.22 per share and has a dividend yield of 6.0%. Temple Bar pays out 20.1% of its earnings in the form of a dividend. CT Private Equity Trust pays out 57.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Temple Bar has a net margin of 74.06% compared to CT Private Equity Trust's net margin of 73.44%. Temple Bar's return on equity of 19.52% beat CT Private Equity Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Temple Bar74.06% 19.52% 7.08%
CT Private Equity Trust 73.44%7.01%1.91%

Temple Bar has a beta of 1.151, suggesting that its share price is 15% more volatile than the broader market. Comparatively, CT Private Equity Trust has a beta of 0.899, suggesting that its share price is 10% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Temple Bar
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
CT Private Equity Trust
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Temple Bar's average media sentiment score of 0.00 equaled CT Private Equity Trust'saverage media sentiment score.

Company Overall Sentiment
Temple Bar Neutral
CT Private Equity Trust Neutral

10.7% of Temple Bar shares are held by institutional investors. Comparatively, 16.8% of CT Private Equity Trust shares are held by institutional investors. 0.2% of Temple Bar shares are held by company insiders. Comparatively, 0.3% of CT Private Equity Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Temple Bar beats CT Private Equity Trust on 8 of the 15 factors compared between the two stocks.

How does CT Private Equity Trust compare to IntegraFin?

IntegraFin (LON:IHP) and CT Private Equity Trust (LON:CTPE) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

IntegraFin has a beta of 1.276, suggesting that its stock price is 28% more volatile than the broader market. Comparatively, CT Private Equity Trust has a beta of 0.899, suggesting that its stock price is 10% less volatile than the broader market.

IntegraFin pays an annual dividend of GBX 11.30 per share and has a dividend yield of 3.1%. CT Private Equity Trust pays an annual dividend of GBX 28.22 per share and has a dividend yield of 6.0%. IntegraFin pays out 59.2% of its earnings in the form of a dividend. CT Private Equity Trust pays out 57.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CT Private Equity Trust is clearly the better dividend stock, given its higher yield and lower payout ratio.

CT Private Equity Trust has a net margin of 73.44% compared to IntegraFin's net margin of 28.60%. IntegraFin's return on equity of 27.60% beat CT Private Equity Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
IntegraFin28.60% 27.60% 20.29%
CT Private Equity Trust 73.44%7.01%1.91%

44.0% of IntegraFin shares are owned by institutional investors. Comparatively, 16.8% of CT Private Equity Trust shares are owned by institutional investors. 14.5% of IntegraFin shares are owned by insiders. Comparatively, 0.3% of CT Private Equity Trust shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, IntegraFin's average media sentiment score of 0.00 equaled CT Private Equity Trust'saverage media sentiment score.

Company Overall Sentiment
IntegraFin Neutral
CT Private Equity Trust Neutral

IntegraFin has higher revenue and earnings than CT Private Equity Trust. CT Private Equity Trust is trading at a lower price-to-earnings ratio than IntegraFin, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IntegraFin£165.40M7.33£52.54M£19.1019.22
CT Private Equity Trust£36.40M9.21£5.40M£49.049.58

IntegraFin presently has a consensus target price of GBX 435, indicating a potential upside of 18.47%. Given IntegraFin's higher probable upside, research analysts plainly believe IntegraFin is more favorable than CT Private Equity Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IntegraFin
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
CT Private Equity Trust
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

IntegraFin beats CT Private Equity Trust on 10 of the 16 factors compared between the two stocks.

Get CT Private Equity Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTPE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTPE vs. The Competition

MetricCT Private Equity TrustCapital Markets IndustryFinance SectorLON Exchange
Market Cap£335.22M£5.43B£13.97B£2.87B
Dividend Yield6.04%7.50%5.95%6.25%
P/E Ratio9.5830.2825.55367.04
Price / Sales9.211,212.49507.9189,972.84
Price / Cash22.6947.9230.3027.89
Price / Book0.703.522.756.31
Net Income£5.40M£417.39M£1.32B£5.89B
7 Day Performance-0.84%-1.65%-1.24%-1.13%
1 Month Performance-6.00%-2.06%-0.33%-0.60%
1 Year Performance-0.63%2.19%8.20%19.59%

CT Private Equity Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTPE
CT Private Equity Trust
N/AGBX 470
flat
N/A+0.4%£335.22M£36.40M9.58N/A
ASL
Aberforth Smaller Companies Trust
N/AGBX 1,759.57
0.0%
N/A+11.7%£1.34B£94.68M15.20N/A
WWH
Worldwide Healthcare
N/AGBX 383.15
-0.9%
N/A+11.5%£1.34B£118.16M14.35N/A
JMG
JPMorgan Emerging Markets
N/AGBX 135.80
-0.9%
N/A+8.6%£1.33B£56.31M29.33N/A
TMPL
Temple Bar
N/AGBX 417.09
-0.4%
N/A+18.4%£1.28B£222.42M5.55N/A

Related Companies and Tools


This page (LON:CTPE) was last updated on 9/14/2026 by MarketBeat.com Staff.
From Our Partners